Navigation Links
Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results
Date:11/17/2009

trial for multiple myeloma
  • Richard Dondero, Vice President of Research & Development at Senesco, delivered the Company's corporate presentation at the 11th Annual Rodman & Renshaw Healthcare Conference
  • "SNS-01 continues to demonstrate potential as a possible treatment for multiple myeloma, most recently being the subject of a poster presentation at one of the most important oncology conferences of the year, the annual AACR-NCI-EORTC Conference," said Jack Van Hulst, President and Chief Executive Officer of Senesco.

    The Company did not record any revenue for the three month period ended September 30, 2009. Total revenues of $200,000 for the three month period ended September 30, 2008 consisted of a milestone payment in connection with an agricultural license agreement.

    Research and development expenses during the three month period ended September 30, 2009 were $575,291, compared with $504,386 during the three month period ended September 30, 2008, an increase of 14.1%. This increase was primarily a result of an $89,000 loss on the extinguishment of debt in connection with the issuance of common stock and warrants to Cato Holding Company in exchange for debt that was owed by Senesco to Cato Research Ltd. in the amount of $175,000, which was slightly offset by decrease in the cost of the research performed at the University of Waterloo as a result of the stronger U.S. dollar against the Canadian dollar.

    General and administrative expenses were $494,955 for the three month period ended September 30, 2009, compared with $529,865 during the three month period ended September 30, 2008, a decrease of 6.6%. This decrease was due primarily to a $34,000 decrease in stock based compensation, and a $20,000 decrease in professional fees, which were a result of a decrease in legal and accounting fees related to the review of our securities filings. These decreases were slightly offset by a $15,000 i
    '/>"/>

    SOURCE Senesco Technologies, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
    2. Senesco Announces H1N1 Influenza Survival Test Results in Mice
    3. Senesco Chooses VGXI to Produce Factor 5A Plasmid
    4. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
    5. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
    6. Senesco Technologies Initiates Preclinical Studies for Cancer Target
    7. EF Johnson Technologies Announces Third Quarter Results
    8. Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
    9. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
    10. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
    11. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... Dec. 19, 2014 In today,s increasingly ... web presence to reflect the needs of a ... must meet the needs of key stakeholders while ... According to recent research by benchmarking ... the participating companies averaged more than $100,000 in ...
    (Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , Dec. ... SRNE ;  Sorrento), an oncology company developing ... Conkwest, Inc., a privately-held immuno-oncology company developing proprietary ... cell-line based therapy, announced today that the companies ... develop next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies ...
    (Date:12/19/2014)... 18, 2014 Research and Markets ... the "Micro Market Monitor: North American Dermatology ... http://photos.prnewswire.com/prnh/20130307/600769 ... steadily, which has resulted in fueling the overall ... main purpose of these dermatology devices is to ...
    Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
    (Date:12/21/2014)... Dennis Thompson HealthDay Reporter ... find e-cigarettes less addictive than traditional cigarettes, new research finds. ... they did regular cigarettes, thousands of ex-smokers said they have ... irritable over their need to smoke, researchers reported. ... significantly less for e-cig use than for tobacco use," said ...
    (Date:12/21/2014)... (PRWEB) December 21, 2014 AlignLife of ... in need while at the same time helping people get ... a non-profit community-based organization committed to serving those persons in ... their needs to improve the quality of life. Dr. Michael ... an impact in the local community and he knew he ...
    (Date:12/21/2014)... CA (PRWEB) December 21, 2014 Over ... resolved performance issues in hundreds of emergency departments across ... satisfaction. Its findings have been translated into an innovative ... leaders to correct deficiencies and enhance the patient experience. ... outsourced emergency physician staffing and management services for hospitals, ...
    (Date:12/21/2014)... (PRWEB) December 21, 2014 As ... alleging heart attacks, stroke and blood clots from using ... increase, a new study shows that the male hormone ... cancer. In a study published in the Proceedings of ... James Amos-Landgraf examined a group of male rats with ...
    (Date:12/21/2014)... Concept Plus, LLC. a SDB and ... Fairfax, VA., today announced it has been recognized by ... which ranks the fastest growing government contracting small businesses by ... , This is the first year that Concept Plus, LLC., ... with a 95.92% compound annual growth rate. “For Concept Plus ...
    Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2
    ... eating your apple a day" Perhaps you should be. ... a significantly reduced risk of metabolic syndrome, a cluster of ... as diabetes and cardiovascular disease. , The study ... were derived from an analysis of adult food consumption data ...
    ... RATON, Fla., April 8, 2008 It,s common knowledge,that ... as they,age. Heart disease is the leading cause of ... are staggering: one in two men and one in ... aware are we that,scientific studies suggest that resveratrol and ...
    ... be the most actively-used PHR in the market, ... that more than 2 million members are actively using ... shows that consumers find,Kaiser Permanente,s personal health record an ... in the market are finding it difficult to attract,users, ...
    ... Partner Will Serve 2008-2009 Term, FREDERICK, Md., April ... a full-service accounting and management,consulting firm, was recently elected ... Health Care Advisors Association (HCAA). He,will begin his one-year ... will be responsible for facilitating the,transition of a new ...
    ... CryoLife, Inc. (NYSE:,CRY) a biomaterials, medical ... William F. Northrup, III, M.D. has joined ... education, reporting to Steven G.,Anderson, president and ... Dr. Northrup, a board-certified,cardiovascular surgeon, will create ...
    ... of Dry-Patch ... Vaccine -, GAITHERSBURG, ... it will receive a,cost-reimbursement grant for up to $943,856 from the U.S. ... version of the anthrax vaccine., Under the 1-year grant, Iomai scientists ...
    Cached Medicine News:Health News:Adults who eat apples, drink apple juice have lower risk for metabolic syndrome 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2Health News:Two Million People Using Kaiser Permanente's Personal Health Record 2Health News:Brian Bastis Elected as National CPA Health Care Advisors Association Executive Committee President 2Health News:William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education 2Health News:William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education 3Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 2Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 3Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 4
    An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
    ... With the Hertel, the ... hands and held firmly against ... line with the center of ... against the two temporal orbital ...
    Hertel exophthalmometer is used for precise exophthalmos measurements (e.g. exophthalmic goiter)....
    Naugle exophthalmometer is superior and inferior orbital rim-based instrument....
    Medicine Products: